Literature DB >> 21804397

Extrapulmonary lymphangioleiomyomatosis in pelvic and paraaortic lymph nodes associated with uterine cancer: a report of 3 cases.

Yoko Iwasa1, Mayumi Tachibana, Hiroko Ito, Shuichiro Iwami, Haruhiko Yagi, Shigetoshi Yamada, Atsuhiko Okagaki, Chiaki Ban, Masayuki Mano, Yoshinori Kodama, Makiko Ueda.   

Abstract

We report 3 cases of extrapulmonary lymphangioleiomyomatosis incidentally found in pelvic and paraaortic lymph nodes in association with uterine cancers. Three women, 47-year-old, 59-year-old, and 71-year-old, respectively, had uterine cancers and underwent hysterectomy, bilateral salpingo-oophorectomy, and pelvic and paraaortic lymph node excision. None of the 3 patients had tuberous sclerosis complex or lymphangioleiomyomatosis in other organs. None had any history of extrinsic hormonal administration. The postoperative pathologic diagnoses were uterine cervical squamous cell carcinoma for the first patient and endometrioid adenocarcinomas for the second and the third patients. Besides these malignant lesions, all 3 patients showed spindle cell proliferation, 2 to 5 mm in size, in 1 to 8 foci of the pelvic and paraaortic lymph nodes. The spindle cells having small polygonal nuclei and inconspicuous nucleoli with palely eosinophilic cytoplasm, reminiscent of immature smooth muscle cells, proliferated in nested and whorling patterns. Neither cellular atypia nor mitotic figures were observed. Immunohistochemically, these spindle cells were positive for α-Smooth Muscle Actin, Desmin, HMB45, Microphthalmia Transcription Factor, Estrogen receptor, and Progesterone receptor. And the network of the vascular-like channels surrounded by these spindle cells was positive for D2-40. From the pathologic and immunohistochemical findings, the spindle cell proliferation in the lymph nodes is best interpreted as lymphangioleiomyomatosis.

Entities:  

Mesh:

Year:  2011        PMID: 21804397     DOI: 10.1097/PGP.0b013e318212e1e6

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN: 0277-1691            Impact factor:   2.762


  4 in total

Review 1.  Diagnostic management of occult nodal lymphangioleiomyomatosis detected during pelvic cancer staging. Localized finding or systemic disease?

Authors:  Andrea Remo; Caterina Zanella; Pietro Parcesepe; Filippo Greco; Massimo Pancione; Mara Maria Zapparoli; Erminia Manfrin; Claudio Micheletto
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2019-05-01       Impact factor: 0.670

Review 2.  Pelvic lymphangioleiomyomatosis treated successfully with everolimus: Two case reports with literature review.

Authors:  Sharjil Wahid; Ping Chia Chiang; Hao Lun Luo; Shun-Chen Huang; Eing-Mei Tsai; Po Hui Chiang
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

3.  Pelvic Lymph Node Lymphangiomyomatosis Found During Surgery for Gynecological Fallopian Tube Cancer: A Case Report and Literature Review.

Authors:  Shan Xiao; Yijia Chen; Qianjue Tang; Lianwei Xu; Li Zhao; Zhenzhen Wang; Erkai Yu
Journal:  Front Med (Lausanne)       Date:  2022-07-15

4.  A case of lymphangioleiomyomatosis associated with endometrial cancer and severe systemic lupus erythematosus.

Authors:  Kensuke Suzuki; Kazunori Nagasaka; Katsutoshi Oda; Hiroyuki Abe; Daichi Maeda; Yoko Matsumoto; Takahide Arimoto; Kei Kawana; Masashi Fukayama; Yutaka Osuga; Tomoyuki Fujii
Journal:  BMC Cancer       Date:  2016-07-04       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.